Vernalis (VER)


Latest News

Total Voting Rights

RNS Number: 2499A Vernalis PLC 29 December 2017 TOTAL VOTING RIGHTS VERNALIS PLC (the "Company") 29 December 2017 Vernalis plc (LSE: VER) announces that the Company's total issued share capital at the date of this announcement is 526,819,624 ordinary shares of 1p each, with one voting right per share. There are no shares held in treasury. The to...

Second Price Monitoring Extn

RNS Number: 3917A Vernalis PLC 27 December 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined percen...

Price Monitoring Extension

RNS Number: 3909A Vernalis PLC 27 December 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occ...

Vernalis Results of Annual General Meeting

RNS Number: 2977Z Vernalis PLC 14 December 2017 14 December 2017 LSE: VER Vernalis Results of Annual General Meeting Resolutions Vernalis plc (LSE: VER) announces that all resolutions proposed to shareholders at its Annual General Meeting held today were duly passed. All resolutions were approved on a show of hands. The number of proxy votes received...

All News

29-12-17Total Voting RightsRNS
27-12-17Second Price Monitoring ExtnRNS
27-12-17Price Monitoring ExtensionRNS
14-12-17Vernalis Results of Annual General MeetingRNS
14-12-17Vernalis reports steady growth in Tuzistra XRStockMarketWire
14-12-17AGM StatementRNS
13-12-17Vernalis partners with Daiichi SankyoStockMarketWire
13-12-17Vernalis + Daiichi Sankyo Enter CollaborationRNS
06-12-17Vernalis receives Servier milestone paymentStockMarketWire
06-12-17Vernalis and Servier Achieve Research MilestoneRNS
05-12-17Second Price Monitoring ExtnRNS
05-12-17Price Monitoring ExtensionRNS
30-11-17Total Voting RightsRNS
02-11-17Notice of Annual Report and AGMRNS
31-10-17Total Voting RightsRNS
29-09-17Block listing Interim ReviewRNS
12-09-17Vernalis sales beat market expectationsStockMarketWire
12-09-17Results Announcement for the Year Ended 30/06/2017RNS
07-08-17FDA Issues Complete Response Letter on CCP-08 NDARNS
28-07-17Broker Forecast - Cantor Fitzgerald issues a broker note on Vernalis PLCStockMarketWire
18-07-17Vernalis anticipates sales to be expectationsStockMarketWire
18-07-17Year-End Trading Update and Notice of ResultsRNS
30-06-17Total Voting RightsRNS
31-05-17Total Voting RightsRNS
28-04-17Total Voting RightsRNS
26-04-17Vernalis and Servier announce three milestonesStockMarketWire
26-04-17Servier and Vernalis announce 3 milestonesRNS
21-04-17Broker Forecast - Panmure Gordon issues a broker note on Vernalis PLCStockMarketWire
21-04-17Broker Forecast - Stifel issues a broker note on Vernalis PLCStockMarketWire
21-04-17FTSE struggles as dominant blue-chips fall StockMarketWire
21-04-17FTSE ahead as miners up with industrial metals pricesStockMarketWire
21-04-17Vernalis to resubmit NDA to US FDA for drug CCP-07StockMarketWire
21-04-17Vernalis receives $2 million milestone paymentRNS
21-04-17FDA Issues Complete Response Letter on CCP-07 NDARNS
04-04-17Broker Forecast - Stifel issues a broker note on Vernalis PLCStockMarketWire
29-03-17Block listing Interim ReviewRNS
20-03-17Broker Forecast - N+1 Singer issues a broker note on Vernalis PLCStockMarketWire
06-03-17Vernalis, Servier in new drug discovery collaborationStockMarketWire
06-03-17New drug discovery collaboration with ServierRNS
28-02-17Total Voting RightsRNS

RSS feeds

  • Editorial news feed for LSE:VER Editorial
  • Regulatory news feed for LSE:VER Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account